Literature DB >> 25456296

Osteoarthritis year in review 2014: highlighting innovations in basic research and clinical applications in regenerative medicine.

G J V M van Osch1.   

Abstract

Regenerative medicine is an emerging area that will influence the treatment of joint diseases in the future. It involves the use of biomaterials, cell therapy, and bioactive factors such as growth factors, drugs and small molecules, to regenerate damaged tissues. This "year in review" highlights a personal selection of promising studies published between March 2013 and March 2014 that inform on the direction in which this field is moving. This multidisciplinary field has been very active, with rapid development of new technologies that emerge from basic sciences such as the possibility to generate pluripotent stem cells without genetic modification and genetic engineering of growth factors to enhance their capacity to induce tissue repair. The increasing knowledge of the interaction between all tissues in the joint, such as the effect of bone remodeling and synovial inflammation on cartilage repair, will eventually make tissue regeneration in a compromised joint environment possible.
Copyright © 2014 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biomaterials; Cartilage; Growth factors; Regenerative medicine; Stem cells

Mesh:

Substances:

Year:  2014        PMID: 25456296     DOI: 10.1016/j.joca.2014.07.022

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  2 in total

1.  Effects of Tribulus terrestris on monosodium iodoacetate‑induced osteoarthritis pain in rats.

Authors:  Young Jin Park; Young-Rak Cho; Joa Sub Oh; Eun-Kyung Ahn
Journal:  Mol Med Rep       Date:  2017-08-21       Impact factor: 2.952

2.  Scaffold-free approach produces neocartilage tissue of similar quality as the use of HyStem™ and Hydromatrix™ scaffolds.

Authors:  Janne H Ylärinne; Chengjuan Qu; Mikko J Lammi
Journal:  J Mater Sci Mater Med       Date:  2017-02-16       Impact factor: 3.896

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.